Stockscreener 앱 받기
0.8064
6.67%
-0.0576
전일 마감가:
$0.864
열려 있는:
$0.8331
하루 거래량:
76,250
Relative Volume:
0.00
시가총액:
$4.00M
수익:
순이익/손실:
$-7.10M
주가수익비율:
-0.152
EPS:
-5.3059
순현금흐름:
$-8.30M
1주 성능:
-6.23%
1개월 성능:
-28.00%
6개월 성능:
-36.25%
1년 성능:
-80.69%
1일 변동 폭
$0.8064
$0.8497
1주일 범위
$0.76
$0.9701
52주 변동 폭
$0.6032
$4.66
Dermata Therapeutics Inc Stock (DRMA) Company Profile
명칭
Dermata Therapeutics Inc
전화
(858)-223-0882
주소
3525 DEL MAR HEIGHTS RD., #322, SAN DIEGO
Compare DRMA vs VRTX, REGN, MRNA, ARGX, ONC
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
DRMA
Dermata Therapeutics Inc
|
0.8064 | 4.00M | 0 | -7.10M | -8.30M | -5.3059 |
VRTX
Vertex Pharmaceuticals Inc
|
527.07 | 133.59B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
809.59 | 83.35B | 14.92B | 4.42B | 3.79B | 41.04 |
MRNA
Moderna Inc
|
206.40 | 82.40B | 2.23B | -3.19B | -1.60B | -8.1462 |
ARGX
Argen X Se Adr
|
880.05 | 55.34B | 4.16B | 1.29B | 734.26M | 19.58 |
ONC
Beone Medicines Ltd Adr
|
377.19 | 42.67B | 5.76B | 514.49M | 1.10B | 4.4813 |
Dermata Therapeutics Inc 주식(DRMA)의 최신 뉴스
After exercising options at $39.42, PTC Therapeutics (PTCT) CLO Boulding sells 192 shares. - Stock Titan
Under a trading plan, Section Six sells 2,500 PTC Therapeutics (PTCT) shares. - Stock Titan
Form S-3 Dermata Therapeutics Inc For: 9 October By Investing.com - Investing.com India
Form S-3 Dermata Therapeutics Inc For: 9 October By Investing.com - Investing.com Nigeria
CEO David Kirn sells 58,061 and 272 shares of 4D Molecular Therapeutics (FDMT) under a trading plan. - Stock Titan
At $2.18 a share, Ingmar Bruns acquires 9,727 shares in Zentalis Pharmaceuticals (ZNTL). - Stock Titan
At $1.97 a share, enGene Therapeutics (ENGN) interim medical chief bought 5,102 shares. - Stock Titan
A $15 IPO brought share purchases and preferred-stock conversions at Electra Therapeutics (ETRA). - Stock Titan
Travere Therapeutics (TVTX) CEO trades 400K shares under preset plan - Stock Titan
Halozyme (HALO) director sells nearly 19,000 shares - Stock Titan
Dermata Therapeutics, Inc.Common Stock (NQ: DRMA - FinancialContent
12 Health Care Stocks Moving In Tuesday's After-Market Session - Benzinga
Dermata Therapeutics Inc. Warrant (DRMAW) Peer Comparison – Compare with Others - Value Research
Insider at Tango Therapeutics (TNGX) sells 27,000 shares in preset plan - Stock Titan
Spyre Therapeutics (SYRE) CEO sells shares in preset plan - Stock Titan
Dermata Therapeutics Inc. Warrant (DRMAW) Financials – Balance Sheet, Profit & Loss, Cash Flow - Value Research
Nasdaq starts delisting Crinetics (NASDAQ: CRNX) shares and ends its Section 12(b) listing - Stock Titan
Dermata Therapeutics (DRMA) Drops 8.22% to $1.34 as Selling Pressure Drags Micro-Cap Biotech LowerMAMA Signal - vinanet.vn
Dermata Therapeutics (DRMA) Slides 8.22% as Shares Press Toward Key $1.27 SupportPost-Earnings Moves - dars.gov.et
Dermata launches first direct-to-consumer skincare product By Investing.com - Investing.com UK
Dermata launches first direct-to-consumer skincare product - Investing.com
Dermata (DRMA) Latest Quarter: Reported EPS Misses Expectations in the Current Update; Closing Move: Shares Move 2.90% Up for the Current SessionAnnual Report - vinanet.vn
Dermata Therapeutics (NASDAQ:DRMA) Commercial Strategy Gains Attention - kalkinemedia.com
Dermata opens preorders for Tome skincare product - Investing.com
Dermata opens preorders for Tome skincare product By Investing.com - Investing.com Canada
Dermata opens preorders for Tome skincare product By Investing.com - Investing.com Nigeria
Dermata opens preorders for Tome skincare product By Investing.com - Investing.com UK
Dermata Announces Preorders Now Open for Tome Foundational Treatment Ahead of Commercial Launch - Newswire.com
Dermata (DRMA) Results Check: EPS Comes in Below Forecast in the Latest Reading; Market Response: Shares Move 2.80% Up for the Current SessionStrong Earnings Momentum - vinanet.vn
Dermata (NASDAQ: DRMA) ends Nasdaq listing for warrants - Stock Titan
Dermata Therapeutics raises $3.4 million in private placement - Investing.com
Dermata Therapeutics Announces Private Placement to Fund DTC Pivot - TipRanks
Form 8K Dermata Therapeutics Inc For: 17 August By Investing.com - Investing.com South Africa
Form 8K Dermata Therapeutics Inc For: 17 August By Investing.com - Investing.com Australia
Form 8K Dermata Therapeutics Inc For: 17 August By Investing.com - Investing.com Nigeria
Dermata Therapeutics raises $3.4 million in private placement By Investing.com - Investing.com Canada
Form 8K Dermata Therapeutics Inc For: 17 August By Investing.com - Investing.com India
Form 8K Dermata Therapeutics Inc For: 17 August By Investing.com - Investing.com UK
Dermata Therapeutics Announces $3.4 Million Private Placement Priced At-The-Market Under Nasdaq Rules - ACCESS Newswire
Dermata Therapeutics Raises $3.2 Million in Private Placement; Investors Get Resale Rights - TradingView
Dermata Therapeutics Announces $3.4 Million Private Placement Priced At-The-Market Under Nasdaq Rules - Weatherford Democrat
Dermata Therapeutics Announces $3.4 Million Private Placement Priced At-The-Market Under Nasdaq Rules - Yahoo Finance
Dermata Therapeutics raises $3.4 million in private placement By Investing.com - Investing.com UK
Dermata Therapeutics, Inc. announced that it expects to receive $3.347307 million in funding - marketscreener.com
DRMA Q2 2026 Earnings: Wider-Than-Expected Loss Despite 13.8% Share Price AdvanceGross Profit Margin - vinanet.vn
Why CoreWeave Shares Are Trading Higher By Over 17%; Here Are 20 Stocks Moving Premarket - Sahm
DRMA|Dermata Therapeutics Inc|Price:1.370|Chg%:+0.290 - TradingKey
Dermata Therapeutics Stock Surges 27% Pre-Market: Why is it Moving? - webull.com
12 Health Care Stocks Moving In Wednesday's Intraday Session - Benzinga
Unusual volume stocks are being observed in Wednesday's session. - ChartMill
Dermata Therapeutics Inc (DRMA) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Dermata Therapeutics Inc 주식 (DRMA) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Bedoya-Toro Munera Maria E | SVP, Regulatory Affairs |
Feb 17 '26 |
Buy |
1.27 |
1,000 |
1,270 |
1,012 |
3.09%
0.17%
자본화:
|
볼륨(24시간):